Application of real-time quantitative RT-PCR for improving the diagnosis, treatment, and control of bovine Anaplasmosis

dc.contributor.authorReinbold, James Brandon
dc.date.accessioned2009-12-17T14:43:39Z
dc.date.available2009-12-17T14:43:39Z
dc.date.graduationmonthDecemberen_US
dc.date.issued2009-12-17T14:43:39Z
dc.date.published2009en_US
dc.description.abstractThe Office International des Epizooties (OIE) Animal Health Code categorizes bovine anaplasmosis as a notifiable disease. Many species of the genus Anaplasma cause anaplasmosis. Co-infections with two or more Anaplasma spp. occur in cattle. A competitive ELISA is regarded as a reliable test for identifying A. marginale-infected cattle. However, cross-reactivity among related Anaplasma spp. has been reported when using cELISA. In the absence of effective treatment strategies and vaccine availability, anaplasmosis control strategies are primarily focused on disease identification and prevention and development of chemosterilization strategies. Four studies were completed to improve the diagnosis, treatment, and control of bovine anaplasmosis. In the first study, a real-time qRT-PCR was developed to detect as few as 100 copies of 16S rRNA of both A. marginale and A. phagocytophilum in the same reaction. This detection limit was equitable to the minimum infective unit of one A. marginale bacterium. In the second study, qRT-PCR results determined needle-free injection was superior to needle injection for controlling iatrogenic transmission of A. marginale in cattle. The qRT-PCR demonstrated 100% sensitivity by 21 days post-infection and 21 days prior to 100% sensitivity with cELISA. The third study determined the pharmacokinetic parameters of chlortetracycline in group fed, ruminating Holstein steers: volume of distribution (40.9 L⁄kg); rate constant (0.0478 h-1); dose-normalized area under the curve (0.29 h•µg⁄L); clearance (1.8 L⁄kg⁄h); elimination half-life (16.2 h); maximum concentration/dose (4.5 ng⁄mL); and time of maximum concentration (23.3 h). Dose linearity was confirmed for oral chlortetracycline dosages of 4.4, 11, and 22 mg/kg/day. The final study established an in vivo pharmacokinetic-pharmacodynamic relationship between chlortetracycline and anaplasmosis carrier clearance in bovine plasma (85.3 ng/mL). The qRT-PCR confirmed chemosterilization of all oral chlortetracycline-treated cattle within 49 days of treatment. Furthermore, qRT-PCR was an effective alternative to the subinoculation of splenectomized cattle for accurate and precise disease classification. The diagnosis, treatment, and control of anaplasmosis were enhanced through the application of qRT-PCR. Further studies are necessary for determining the mechanism of action between chlortetracycline binding to the 30S ribosome of A. marginale and carrier clearance.en_US
dc.description.advisorJohann F. Coetzeeen_US
dc.description.degreeDoctor of Philosophyen_US
dc.description.departmentDepartment of Diagnostic Medicine/Pathobiologyen_US
dc.description.levelDoctoralen_US
dc.description.sponsorshipUSDA CREES 1433 grant (AES Project Number: 481851); AI070908 from the National Institute of Allergy and Infectious Diseases.en_US
dc.identifier.urihttp://hdl.handle.net/2097/2305
dc.language.isoen_USen_US
dc.publisherKansas State Universityen
dc.subjectAnaplasmosisen_US
dc.subjectPCRen_US
dc.subjectPharmacokineticsen_US
dc.subjectchlortetracyclineen_US
dc.subjectBovineen_US
dc.subjectchemosterilizationen_US
dc.subject.umiBiology, Microbiology (0410)en_US
dc.titleApplication of real-time quantitative RT-PCR for improving the diagnosis, treatment, and control of bovine Anaplasmosisen_US
dc.typeDissertationen_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
JamesReinbold2009.pdf
Size:
3.07 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.69 KB
Format:
Item-specific license agreed upon to submission
Description: